Catalent, the Somerset-based clinical supply solutions company, has opened a new full-service facility in Japan, it announced Tuesday.
The company said in a news release that the approximately 64,000-square-foot clinical supply facility, located in the Shiga prefecture, was opened in response to increased demand for services including packaging and more. It will serve both local and global biotech and pharmaceutical companies.
“Shiga will become a key hub in our Asia-Pacific clinical supply services network, with Japan now representing the third-largest clinical trials market in the world,” Roel de Nobel, vice president and general manager of Asia Pacific for Catalent Clinical Supply Services, said in a prepared statement. “The new site builds upon Catalent’s 40 years of in-country presence and, in addition to bilingual English and Japanese product and clinical supply management, will provide primary and secondary packaging and labeling, storage and distribution, cold chain handling, and in-country returns and destruction services.”
The site, acquired from Teva-Takeda Pharmaceuticals in July 2020, represents one of the largest facilities of its kind in Japan, Catalent said.
